Dicloxacillin Capsules Suppliers & Bulk Manufacturers
Available Forms: Oral Capsules
Available Strengths: 250 mg, 500 mg
Reference Brands: Dynapen(US)
Category:
Antibiotics
Dicloxacillin inhibits bacterial cell wall synthesis by targeting penicillin-binding proteins, leading to bacterial lysis. It is effective against penicillinase-producing staphylococci. Benefits include targeted treatment of skin, soft tissue, and bone infections, rapid action, high efficacy, and safety when used as prescribed, especially in resistant staphylococcal infections.
Dicloxacillin Capsules is available in Oral Capsules
and strengths such as 250 mg, 500 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Dicloxacillin Capsules is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Dicloxacillin Capsules can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Dicloxacillin capsules are approved in the EU and US for treating penicillinase-producing staphylococcal infections. In the EU, brands like Dynapen are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data and biosimilarity assessments, with generic options available. Both regions require detailed dossiers and pharmacovigilance plans for approval and ongoing safety monitoring. For expert support with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate efficient market access for dicloxacillin capsules, ensuring adherence to European and US standards for safe, effective antibiotic therapy in resistant bacterial infections.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing